BioPorto Announces Interim Results for the First Six Months of 2023
August 01, 2023 02:48 ET
|
BioPorto A/S
August 1, 2023Announcement no. 14 BioPorto Announces Interim Results for the First Six Months of 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, August 1, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S...
BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call
July 07, 2023 08:55 ET
|
BioPorto A/S
July 7, 2023News Release BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call COPENHAGEN, Denmark and BOSTON, MA, USA, July 7, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto...
BioPorto Announces Submission of Response to FDA Additional Information Letter
June 29, 2023 02:11 ET
|
BioPorto A/S
June 29, 2023News release BioPorto Announces Submission of Response to FDA Additional Information Letter COPENHAGEN, DENMARK and BOSTON, MA, June 29, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto...
Managers’ transactions
June 28, 2023 09:50 ET
|
BioPorto A/S
June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in...
BioPorto A/S announces completion of rights issue; total number of shares and voting rights
June 23, 2023 01:49 ET
|
BioPorto A/S
June 23, 2023Announcement no. 12 BioPorto A/S announces completion of rights issue; total number of shares and voting rights COPENHAGEN, Denmark and BOSTON, MA, USA, June 23, 2023, (GLOBE NEWSWIRE)...
BioPorto A/S announces results of rights issue
June 21, 2023 07:52 ET
|
BioPorto A/S
June 21, 2023Announcement no. 11 BioPorto A/S announces results of rights issue COPENHAGEN, Denmark and BOSTON, MA, USA, June 21, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (“BioPorto” or the “Company”)...
BioPorto A/S to Webcast with HCA and Nordnet regarding the ongoing rights issue
June 09, 2023 09:38 ET
|
BioPorto A/S
June 9, 2023News release BioPorto A/S to Webcast with HCA and Nordnet regarding the ongoing rights issue ...
BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments
May 30, 2023 11:27 ET
|
BioPorto A/S
May 30, 2023Announcement no. 10 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN...
Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act
May 23, 2023 14:02 ET
|
BioPorto A/S
May 23, 2023Announcement no. 9 Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets...
BioPorto Announces Interim Results for the First Three Months of 2023
May 10, 2023 02:20 ET
|
BioPorto A/S
May 10, 2023Announcement no. 8 BioPorto Announces Interim Results for the First Three Months of 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, May 10, 2023, (GLOBE NEWSWIRE) -- BioPorto...